Abstracts deadline Friday 24 April 2026! Submit now
Abstracts deadline EXTENDED Friday 22 May 2026! Submit now
Missed out on APLAR 2026? Check out what you missed here!
As an APLAR 2026 attendee, you can re-watch all streamed content for 12 months! Watch the sessions you missed, or revisit over 250 expert presentations from the comfort of your home or office through our app. You can still sign up and have 12-month access to the on-demand sessions. See the On-Demand Registration Portal for more information Keep learning from Asia-Pacific’s leading rheumatology experts!
The Asia Pacific League of Associations for Rheumatology (APLAR) is pleased to announce that media accreditation is now open for the 27th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2026), taking place in Seoul, Korea, from 16-19 September 2026. Journalists, editors, broadcasters and media professionals interested in covering one of the region’s leading rheumatology congresses are invited to apply for media accreditation. Approved media representatives will have access to designated congress sessions, exhibition areas and official media resources
In Vivo CAR-T: The Next Standard of Care for Autoimmune Disease? Synopsis: In vivo CAR-T therapy is emerging as a transformative treatment approach for B cell–mediated autoimmune disease, such as systemic lupus erythematosus, systemic scleroderma, and idiopathic inflammatory myopathies, delivering the deep immune reset associated with cell therapy without the complexity and cost of ex vivo manufacturing. As momentum in the field accelerates, CREATE Medicines is bringing together international leaders in cell therapy and rheumatology to explore a thought-provoking question:
Synopsis: This interactive workshop explores the practical use of generative artificial intelligence (GenAI) in rheumatology, with a strong focus on critical thinking, safety, and real-world applicability. Moving beyond the hype, the session will equip participants with the skills to integrate AI tools into clinical, academic, and educational workflows in a rigorous and responsible manner.Through a combination of guided discussions and hands-on exercises, participants will gain experience in applying structured prompting techniques and verification frameworks to improve the quality and reliability
We are excited to announce the release of new videos on the APLAR Congress website. These videos provide updates on the upcoming congress and initiatives from the APLAR cohort. The videos feature messages from various members of the APLAR community, including Prof Tsutomu Takeuchi, Immediate Past President of APLAR and Prof Lai-Shan Tam, President-Elect of APLAR, including many others. Each video offers unique insights and updates about the congress, making them a must-watch for anyone interested in the event. The
We have noticed fraudulent activity from unsupported accommodation providers contacting delegates and speakers to book your accommodation at APLAR Congress. These companies are not supported by APLAR or the congress organisers. If you have been contacted directly to book accommodation, please do not engage, or proceed with booking your hotel. All accommodation bookings can be made with the APLAR congress secretariat via info@aplarcongress.com or directly through the website: https://aplarcongress.com/accommodation/ Please report any suspicious accommodation communications to info@aplarcongress.com
The early bird registration deadline for APLAR 2026 has been extended until 23 June 2026 at 11:59PM — don’t miss your chance to be part of the region’s premier rheumatology event. Join us for five days of world-class speakers, interactive sessions, and unmissable networking opportunities.
The Treat-to-Target Balancing Act in SLE: Control, Compromise and Consequence Objectives: SLE is a heterogeneous, systemic autoimmune disease with significant unmet need despite advances in treatment and the emergence of treat-to-target (T2T) as a guiding principle in rheumatology. In SLE, however, T2T remains particularly challenging because clinicians must balance disease control against organ-specific complexity, safety considerations, steroid burden, patient-reported symptoms such as fatigue, and important life-stage issues including pregnancy and family planning. This symposium will address why T2T in SLE
APLAR Travel Grant Invitation The Asia Pacific League of Associations for Rheumatology (APLAR) cordially invites APLAR Young Rheumatologists (AYR) to apply for the APLAR Congress Travel Grant to attend the APLAR Congress in Seoul, Republic of Korea, from 28 October – 1 November 2026. APLAR will award 50 need-based travel stipends to AYR members who have an accepted abstract for a poster, oral, or rapid-fire presentation at the APLAR Congress 2026. The grant assists AYR in covering part of the
Have you registered yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
